- Home
- CNTX vs STEM Comparison
CNTX vs STEM Comparison
Compare CNTX & STEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- STEM
- Stock Information
- Founded
- CNTX 2015
- STEM 2009
- Country
- CNTX United States
- STEM United States
- Employees
- CNTX N/A
- STEM N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- STEM Computer Software: Prepackaged Software
- Sector
- CNTX Health Care
- STEM Technology
- Exchange
- CNTX Nasdaq
- STEM Nasdaq
- Market Cap
- CNTX 78.0M
- STEM 75.7M
- IPO Year
- CNTX 2021
- STEM N/A
- Fundamental
- Price
- CNTX $0.58
- STEM $0.42
- Analyst Decision
- CNTX Strong Buy
- STEM Hold
- Analyst Count
- CNTX 4
- STEM 9
- Target Price
- CNTX $6.00
- STEM $1.17
- AVG Volume (30 Days)
- CNTX 390.0K
- STEM 3.3M
- Earning Date
- CNTX 08-06-2025
- STEM 08-05-2025
- Dividend Yield
- CNTX N/A
- STEM N/A
- EPS Growth
- CNTX N/A
- STEM N/A
- EPS
- CNTX N/A
- STEM N/A
- Revenue
- CNTX N/A
- STEM $151,627,000.00
- Revenue This Year
- CNTX N/A
- STEM $5.72
- Revenue Next Year
- CNTX N/A
- STEM $19.61
- P/E Ratio
- CNTX N/A
- STEM N/A
- Revenue Growth
- CNTX N/A
- STEM N/A
- 52 Week Low
- CNTX $0.49
- STEM $0.29
- 52 Week High
- CNTX $2.75
- STEM $1.68
- Technical
- Relative Strength Index (RSI)
- CNTX 44.00
- STEM 41.92
- Support Level
- CNTX $0.56
- STEM $0.42
- Resistance Level
- CNTX $0.63
- STEM $0.48
- Average True Range (ATR)
- CNTX 0.08
- STEM 0.06
- MACD
- CNTX 0.00
- STEM -0.02
- Stochastic Oscillator
- CNTX 27.68
- STEM 7.46
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About STEM Stem Inc.
Stem Inc is a provider of energy storage systems. The company bundles third-party hardware with its proprietary Athena software to provide customers a turnkey solution. Stem sells its solutions to commercial and industrial customers as well as independent power producers and renewable developers. Its solutions help customers maximize renewable energy generation and help build a cleaner and more resilient grid. The Company operates as one operating segment that is focused exclusively on technology services that transform the way energy is distributed and consumed.